新生儿Dubin-Johnson综合征的临床、病理与遗传特征:日本多中心研究
所有患儿均表现为胆汁淤积,仅38%肝活检见黑色肝或色素沉积,但全部肝标本MRP2表达缺失且检出ABCC2致病变异。结论认为MRP2免疫组化和ABCC2基因分析对准确诊断至关重要。
要点
- 新生儿Dubin-Johnson综合征均以胆汁淤积起病,表现为黄疸延长伴或不伴无胆色粪。
- 肝活检黑色肝或色素沉积仅见于38%早期婴儿患者,易漏诊。
- 所有肝标本MRP2表达缺失,且全部检出ABCC2双等位致病变异。
核心结论
- 肝组织MRP2免疫组化染色和ABCC2分子遗传学分析对新生儿Dubin-Johnson综合征的准确诊断至关重要。
主要发现
- 所有新生儿均表现胆汁淤积,即黄疸延长伴或不伴无胆色粪,以及血清直接胆红素和γ-谷氨酰转移酶或总胆汁酸升高。
- 8例接受肝活检的患者中仅38%(3例)见黑色肝或肝细胞黑色素样色素沉积,活检在婴儿早期进行。
- 免疫组化显示所有肝标本多药耐药相关蛋白2(MRP2)无表达而胆汁酸输出泵蛋白表达增加。
- 所有患者均检出ABCC2纯合或复合杂合致病变异,共11种不同致病变异,其中2种既往未报道。
关键数值与推荐
- 8例肝活检患者中3例(38%)见黑色肝或肝细胞色素沉积。
- 所有患者检出ABCC2纯合或复合杂合致病变异,共11种不同变异,含2种未报道变异。
临床怎么用
- 对新生儿胆汁淤积伴直接胆红素升高者,应考虑Dubin-Johnson综合征,行肝组织MRP2免疫组化和ABCC2基因检测以确诊。
- 不应仅依赖肝活检黑色肝或色素沉积诊断,因早期婴儿阳性率仅38%。
局限性
- 肝活检黑色肝或色素沉积的观察仅基于8例接受活检的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To clarify the clinical, pathologic, and genetic features of neonatal Dubin-Johnson syndrome. STUDY DESIGN: Ten patients with neonatal Dubin-Johnson syndrome were recruited from 6 pediatric centers in Japan between September 2013 and October 2016. Clinical and laboratory course, macroscopic and microscopic liver findings, and molecular genetic findings concerning ATP-binding cassette subfamily C member 2 (ABCC2) were retrospectively and prospectively examined. RESULTS: All neonates exhibited cholestasis, evident as prolonged jaundice with or without acholic stools and elevations of serum direct bilirubin as well as γ-glutamyltransferase or total bile acids. Only 38% (3 of 8) of patients who underwent liver biopsy showed a grossly black liver or melanin-like pigment deposits in hepatocytes; their biopsies were performed in early infancy. Immunohistochemically, all liver specimens showed no expression of multidrug resistance-associated protein 2 but increased expression of the bile salt export pump protein. Homozygous or compound heterozygous pathogenic variants of ABCC2 were identified in all patients, representing 11 distinct pathogenic variants including 2 not previously reported. CONCLUSIONS: Immunohistochemical staining of the liver for multidrug resistance-associated protein 2 and molecular genetic analysis of ABCC2 are crucial for accurate diagnosis of neonatal Dubin-Johnson syndrome.
引用
- Togawa T, Mizuochi T, Sugiura T, et al. Clinical, Pathologic, and Genetic Features of Neonatal Dubin-Johnson Syndrome: A Multicenter Study in Japan. J Pediatr. 2018. PMID: 29499989. doi:10.1016/j.jpeds.2017.12.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。